Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Nanomedicine : Nanotechnology, Biology, and Medicine|April 25, 2016
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cellsReza Nosratabadi, Maryam Rastin, Mojtaba Sankian, et al.Immunopharmacology and Immunotoxicology|December 27, 2024
Crocin as a potential therapeutic agent for multiple sclerosis: insights from experimental autoimmune encephalomyelitis model in miceAlireza Pazoki, Mahbobeh Askaripour, Simin Zargarani, et al.Frontiers in Bioengineering and Biotechnology|July 8, 2025
Lung cancer vaccine strategies: exploring the spectrum from traditional to RNA-based platformsAlireza Pazoki, Sepehr Dadfar, Atefe Alirezaee, et al.Cells|August 9, 2024
Soluble CD40 Ligand as a Promising Biomarker in Cancer DiagnosisAlireza Pazoki, Sepehr Dadfar, Alireza Shadab, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 17, 2026
The crosstalk between iron metabolism and immune tolerance in autoimmunityFatemeh Tavassoli Razavi, Esmaeil Yazdanpanah, Alireza Shadab, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 19, 2025
Therapeutic challenges in breast cancer: Navigating the impact of oxidative stress on treatment efficacy and toxicityDariush Haghmorad, Fatemeh Tavassoli Razavi, Yasamin Eivazzadeh, et al.Molecular Biology Reports|October 28, 2023
Bone marrow mesenchymal stem cells to ameliorate experimental autoimmune encephalomyelitis via modifying expression patterns of miRNAsDariush Haghmorad, Ali Khaleghian, Majid Eslami, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 30, 2025
Nanobody CAR-T cells in cancer: From molecular design to clinical translationAlaa Rifaah Eisa, Fatemeh Tavassoli Razavi, Akram Hoseinzadeh, et al.Biomolecules|January 25, 2025
Lipid Antigens: Revealing the Hidden Players in Adaptive Immune ResponsesTamana Eskandari, Yasamin Eivazzadeh, Fatemeh Khaleghinia, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 17, 2026
Immune checkpoint molecules beyond PD-1 and CTLA-4: emerging targets in autoimmune diseases and cancer immunotherapySepehr Dadfar, Yasamin Eivazzadeh, Haniyeh Molavi, et al.Pageof 6